Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aspire Biopharma Holdings, Inc.
Aspire Biopharma’s Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion
May 17, 2026
Aspire Biopharma’s Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
May 17, 2026
Aspire Biopharma’s Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
May 16, 2026
Aspire Biopharma’s BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
May 16, 2026
Aspire Biopharma’s Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution
February 3, 2026
Aspire Biopharma Secures Agreement with Microsize for Development of Novel Sublingual Aspirin
January 29, 2026
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks
January 27, 2026
Aspire Biopharma’s Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
January 26, 2026
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity
January 22, 2026
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam – Generic Xanax(R) – for Rapid Anxiety Relief
January 20, 2026
1
2
Next Page
→